GURUFOCUS.COM » STOCK LIST » USA » NAS » Grifols SA (NAS:GRFS) » Definitions » 12-1 Month Momentum %
Switch to:

Grifols 12-1 Month Momentum %

: -26.03% (As of Today)
View and export this data going back to 2011. Start your Free Trial

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2022-08-13), Grifols's 12-1 Month Momentum % is -26.03%.

The industry rank for Grifols's 12-1 Month Momentum % or its related term are showing as below:

GRFS's 12-1 Month Momentum % is ranked better than
57.42% of 1118 companies
in the Drug Manufacturers industry
Industry Median: -26.53 vs GRFS: -26.03

Competitive Comparison

For the Drug Manufacturers - General subindustry, Grifols's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Grifols 12-1 Month Momentum % Distribution

For the Drug Manufacturers industry and Healthcare sector, Grifols's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Grifols's 12-1 Month Momentum % falls into.

Grifols  (NAS:GRFS) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grifols  (NAS:GRFS) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

Grifols 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Grifols's 12-1 Month Momentum % provided by Please click on the following links to see related term pages.

Grifols Business Description

Grifols logo
Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and the firm's bioscience business contributed 77% of sales in 2021. Grifols also has smaller segments including diagnostics, hospital supplies, and biosupplies. Diagnostics is now roughly 15% of revenue following the Novartis and Hologic deals.

Grifols Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)